1. Home
  2. NEU vs WGSWW Comparison

NEU vs WGSWW Comparison

Compare NEU & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEU
  • WGSWW
  • Stock Information
  • Founded
  • NEU 1887
  • WGSWW N/A
  • Country
  • NEU United States
  • WGSWW United States
  • Employees
  • NEU N/A
  • WGSWW 1000
  • Industry
  • NEU Major Chemicals
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • Sector
  • NEU Industrials
  • WGSWW Technology
  • Exchange
  • NEU Nasdaq
  • WGSWW Nasdaq
  • Market Cap
  • NEU N/A
  • WGSWW N/A
  • IPO Year
  • NEU N/A
  • WGSWW 2020
  • Fundamental
  • Price
  • NEU $506.82
  • WGSWW $0.19
  • Analyst Decision
  • NEU
  • WGSWW
  • Analyst Count
  • NEU 0
  • WGSWW 0
  • Target Price
  • NEU N/A
  • WGSWW N/A
  • AVG Volume (30 Days)
  • NEU 41.3K
  • WGSWW N/A
  • Earning Date
  • NEU 01-29-2025
  • WGSWW N/A
  • Dividend Yield
  • NEU 1.97%
  • WGSWW N/A
  • EPS Growth
  • NEU 9.11
  • WGSWW N/A
  • EPS
  • NEU 45.05
  • WGSWW N/A
  • Revenue
  • NEU $2,775,261,000.00
  • WGSWW N/A
  • Revenue This Year
  • NEU N/A
  • WGSWW N/A
  • Revenue Next Year
  • NEU N/A
  • WGSWW N/A
  • P/E Ratio
  • NEU $11.25
  • WGSWW N/A
  • Revenue Growth
  • NEU 1.37
  • WGSWW N/A
  • 52 Week Low
  • NEU $494.04
  • WGSWW N/A
  • 52 Week High
  • NEU $650.00
  • WGSWW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NEU 30.54
  • WGSWW N/A
  • Support Level
  • NEU $520.10
  • WGSWW N/A
  • Resistance Level
  • NEU $537.20
  • WGSWW N/A
  • Average True Range (ATR)
  • NEU 11.80
  • WGSWW 0.00
  • MACD
  • NEU -2.25
  • WGSWW 0.00
  • Stochastic Oscillator
  • NEU 3.54
  • WGSWW 0.00

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: